Advertisement

Age and antihypertensive drugs (hydrochlorothiazide, bendroflumethiazide, nadolol and captopril)

  • Edward D. Freis
    Correspondence
    Address for reprints: Edward D. Freis, MD, Hypertension Research, Veterans Administration Medical Center, 50 Irving Street, Northwest, Washington, D.C. 20422.
    Affiliations
    From the Cooperative Studies Program, Medical Research Service, Veterans Administration, Washington, D.C., USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Three double-blind Veterans Administration Cooperative Studies are reviewed to determine age-related changes in response to antihypertensive agents. In the first study 312 patients received hydrochlorothiazide titrated from 25 to 100 mg twice daily to lower diastolic blood pressure (BP) to <90 mm Hg. Of 121 patients aged 55 to 65 the decrease in BP averaged Math Eq mm Hg, while in the 191 patients younger than 55 the reduction averaged Math Eq mm Hg (p < 0.001; p = 0.048, respectively). Both systolic and diastolic BP reductions averaged significantly more in older whites; in older blacks it was systolic BP only. An additional 298 patients received titrated doses of propranolol alone, in this group there were no significant differences in BP response between younger patients and patients aged 55 to 65 except in the subgroup of white patients older than 60, in whom the systolic reduction was significantly less than in the younger patients.
      In a second study of bendroflumethiazide alone and with nadotol, systolic BP decreased more in older than in younger patients but there was no agerelated reduction with nadotol atone. In the third trial captopril was first given atone and later with hydrochlorothiazide. There were no age-related differences with captopril alone, but after the addition of hydrochlorothiazide there was a trend toward a greater antihypertensive response in the patients aged 55 to 69. Thus, responsiveness of older patients varies with the type of antihypertensive drug. Age appears to increase the antihypertensive response to thlazide diuretics but not to β-adrenergic blocking drugs or to captopril.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Messerli FH
        • Sundgaard-Ruse K
        • Ventura HO
        • Dunn FG
        • Glade LB
        • Frohlich ED
        Essential hypertension in the elderly: haemodynomics, intravascular volume, plasma renin activity and circulating catecholamine levels.
        Lancet. 1983; 2: 983-986
        • U.S. Department of Health and Human Services
        Blood pressure levels in persons 18–74 years of age in 1976–1980, and trends in blood pressure from 1960 to 1980 in the United States.
        Vital and Health Statistics, series II, No. 234. July 1986; : 37
        • Roine JW
        Systolic hypertension in the elderly.
        N Engl J Med. 1983; 309: 1246-1247
        • Kannel WB
        • Dawber TR
        • McGee DL
        Perspectives in systolic hypertension. The Framingham study.
        Circulation. 1980; 61: 1179-1182
        • Garland C
        • Barrett-Conner E
        • Suarez L
        • Criqui MH
        Isolated systolic hypertension and mortality after age 60 years.
        Am J Epidemiol. 1983; 118: 365-376
        • Management Committee of the Australian Therapeutic Trial in Mild Hypertension
        Treatment of mild hypertension in the elderly.
        Med J Aust. 1981; 2: 398-402
        • Curb JD
        • Borhani NO
        • Schnaper H
        • Kass E
        • Entwistle G
        • Williams W
        • Bernan R
        Detection and treatment of hypertension in older individuals: the HDFP.
        Am J Epidemiol. 1985; 121: 371-378
        • Veterans Administration Cooperative Study Group on Antihypertensive Agents
        Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences is response.
        JAMA. 1982; 248: 1996-2003
        • Veterans Administration Cooperative Study Group on Antihypertensive Agents
        Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension.
        Am J Cardiol. 1983; 52: 1230-1237
        • Veterans Administration Cooperative Study Group on Antihypertensive Agents
        Low dose captopril for the treatment of mild to moderate hypertension.
        Hypertension. 1983; 5: III-139-III-144
        • Hypertension Detection and Follow-up Program Cooperative Group
        Five-year findings of the hypertension detection and follow-up program II. Mortality by race, sex and age.
        JAMA. 1979; 242: 2572-2577
        • Hansson L
        Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
        Acta Med Scand. 1973; 194: 5-38
        • Menard J
        • Bertagne X
        • N'Guyen PT
        • Degaulet P
        • Carval P
        Rapid identifiation of patients with essential hypertension sensitivity to acebutolol (a new cardio-selective beta-blocker).
        Am J Med. 1976; 60: 886-890
        • Woods JW
        • Pettman AW
        • Pulliam CC
        • Werk Jr, EE
        • Waider W
        • Allen CA
        Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone.
        N Engl J Med. 1976; 294: 1137-1143
        • Buhler FR
        • Burkert K
        • Lutold BE
        • Kung M
        • Morbet G
        • Pfisteren M
        Antihypertensive pathogenetic mechanisms in essential hypertension.
        Am J Cardiol. 1975; 36: 653-669
        • Amery A
        • Birkenhager W
        • Bogaert M
        • Brixko P
        • Bulpitt C
        • Clement D
        • Le-Leeuw P
        • De-Plaen JF
        • Deruyttere M
        • De-Schaepdryuer A
        • Fagard R
        • Forette F
        • Forte J
        • Hamdy R
        • Hellemans J
        • Henry JF
        • Koistinen A
        • Laaser U
        • Laher M
        • Leonetti G
        • Lewis P
        • Lund-Johansen P
        • MacFarlane J
        • Meurer K
        • Miguel P
        • Morris J
        • Mutsers A
        • Nissinen A
        • O'Brien E
        • Ohm OJ
        • O'Malley K
        • Pelemans W
        • Perera N
        • Tuomilehto J
        • Verschueren LJ
        • Willemse P
        • Williams B
        • Zanchetti A
        Antihypertensive therapy in patients above age 60 with systolic hypertension. A progress report of the European Working Party on High Blood Pressure in the Elderly (EWPHE).
        Clin Exp Hypertens. 1982; 4: 1151-1176
        • Lindeman RD
        • Buthilet GN
        • Ashley WR
        • Morris Jr, JR
        Effect of hydrochlorothiazide-reserpine therapy on cerebral function in elderly hypertensive patients.
        J Am Geriatr Soc. 1963; 11: 597-605
        • Freis ED
        Treatment of the elderly hypertensive patient.
        J Am Geriatr Soc. 1955; 3: 710-713
        • Jackson G
        • Mahon E
        • Pierscianowski TA
        • Condon J
        Inappropriate antihypertensive therapy in the elderly.
        Lancet. 1976; 2: 1317-1318
        • Gribbin B
        • Pickering TG
        • Sleight P
        • Peto R
        Effect of age and high blood pressure on baroreflex sensitivity in man.
        Circ Res. 1971; 29: 424-431